Ocular Therapeutix
Category: Autre
mise à jour avec succès: 5 févr. 2020
Auteurs
Created byNathan
Attachments
Les événements
FoundedSeries A
$1.17M
(Undisclosed Investors)Series B
$6.09 M
Pinnacle Ventures
SV Health Investors
Versant Venture ManagementSeries C
$21.53 M
Polaris Partners
SV Health Investors
Versant Venture ManagementSeries D
$23.79 M
Ascension Ventures
Baxter Ventures
Polaris Partners
Sparta Capital Partners
SV Health Investors
Versant Venture ManagementDebt
$20 M
Flexpoint Ford
Silicon Valley BankIPO
$65 MStock Drops 30%Dextenza ApprovedPériodes
Phase 2
Dextenza
Post-Surgical
Inflammation and PainPhase 3
Dextenza
Post-Surgical
Inflammation and Pain
Comments